Diagnostic value of thiols, paraoxonase 1, arylesterase and oxidative balance in colorectal cancer in human

Neoplasma

Volumn 60, Issue 4, 2013, Pages 419-424

  Bulbuller, N ^a   Eren, E ^b   Ellidag, H Y ^a   Oner, O Z ^a   Sezer, C ^a   Aydin, O ^a   Yilmaz, N ^a  

^a Rebuplic of Turkey Ministry of Health Antalya Education and Research Hospital   (Turkey)

^b Anafartalar Caddesi Muratpa a   (Turkey)

Author keywords

Colon cancer; Oxidative stress; Thiols

Indexed keywords

ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE 1; ARYLESTERASE; OXIDIZING AGENT; THIOL; THIOL GROUP; ARYLDIALKYLPHOSPHATASE; CARBOXYLESTERASE; REACTIVE OXYGEN METABOLITE; THIOL DERIVATIVE;

ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; COLON BIOPSY; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MIDDLE AGED; OXIDATIVE STRESS; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; BLOOD; COLORECTAL TUMOR; METABOLISM; OXIDATION REDUCTION REACTION;

ARYLDIALKYLPHOSPHATASE; CARBOXYLIC ESTER HYDROLASES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; SULFHYDRYL COMPOUNDS;

MLCS; MLOWN;

EID: 84880416518     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2013_054     Document Type: Article

References (30)

1. WITTE I, FOERSTERMANN U, DEVARAJAN A, REDDY ST, HORKE S. Protectors or Traitors: The Roles of PON2 and PON3 in Atherosclerosis and Cancer. J Lipids. 2012. http://dx.doi.org/10.1155/2012/342806
2. LOSCALZO J. Paraoxonase and coronary heart disease risk: language misleads, linkage misinforms, function clarifies. Circ Cardiovasc Genet. 2008; 1: 79-80. http://dx.doi.org/10.1161/CIRCGENETICS.108.837179
3. YILMAZ N. Relationship between paraoxonase and homocysteine: crossroads of oxidative diseases. Arch Med Sci. 2012 29; 8: 138-53.
4. DRAGANOV D. Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities J Lipid Res 2005; 46: 1239-47. http://dx.doi.org/10.1194/jlr.M400511-JLR200
5. YILMAZ N, AYDIN O, YEGIN A, TILTAK A, EREN E et al. Impaired oxidative balance and association of blood glucose, insulin and HOMA-IR index in migraine. Biochem Med (Zagreb). 2011; 21: 145-51. http://dx.doi.org/10.11613/BM.2011.023
6. LEUFKENS AM, VAN DUIJNHOVEN FJ, WOUDT SH, SIERSEMA PD, JENAB M, et al. Biomarkers of oxidative stress and risk of developing colorectal cancer: a cohort-nested casecontrol study in the European Prospective Investigation Into Cancer and Nutrition. Am J Epidemiol. 2012; 1: 175:653-63
7. YILMAZ N, AYDIN O, YEGIN A, TILTAK A, EREN E. Increased levels of total oxidant status and decreased activity of arylesterase in migraineurs. Clin Biochem. 2011; 44(10-11): 832-7. http://dx.doi.org/10.1016/j.clinbiochem.2011.04.015
8. BOBIN-DUBIGEON C, JAFFRE I, JOALLAND MP, CLASSE JM, CAMPONE M, et al. Paraoxonase 1 (PON1) as a marker of short term death in breast cancer recurrence. Clin Biochem. 2012 [Epub ahead of print]. http://dx.doi.org/10.1016/j.clinbiochem.2012.05.021
9. BALCI H, GENC H, PAPILA C, CAN G, PAPILA B et al. Serum lipid hydroperoxide levels and paraoxonase activity in patients with lung, breast, and colorectal cancer. J Clin Lab Anal. 2012; 26: 155-60. http://dx.doi.org/10.1002/jcla.21503
10. ARIOZ DT, CAMUZCUOGLU H, TOY H, KURT S, CELIK H et al. Assessment of serum paraoxonase and arylesterase activity in patients with endometrial cancer. Eur J Gynaecol Oncol. 2009; 30: 679-82.
11. ROTHEM L, HARTMAN C, DAHAN A, LACHTER J, ELIAKIM R, et al. Paraoxonases are associated with intestinal inflammatory diseases and intracellularly localized to the endoplasmic reticulum. Free Radic Biol Med. 2007; 43: 730-9. http://dx.doi.org/10.1016/j.freeradbiomed.2007.05.003
12. MACKNESS B, BELTRAN-DEBON R, ARAGONES G, JOVEN J, CAMPS J, et al. Human tissue distribution of paraoxonases 1 and 2 mRNA. IUBMB Life. 2010; 62: 480-2.
13. RODRIGO L, HERNANDEZ AF, LOPEZ-CABALLERO JJ, GIL F, PLA A. Immunohistochemical evidence for the expression and induction of paraoxonase in rat liver, kidney, lung and brain tissue. Implications for its physiological role. Chem Biol Interact. 2001; 137: 123-37. http://dx.doi.org/10.1016/S0009-2797(01)00225-3
14. ROMANI R, DE MEDIO GE, DI TULLIO S, LAPALOMBELLA R, PIRISINU I, et. al. Modulation of paraoxonase 1 and 3 expression after moderate exercise training in the rat. J Lipid Res. 2009; 50: 2036-45. http://dx.doi.org/10.1194/jlr.M800493-JLR200
15. EREL O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005; 38: 1103-11. http://dx.doi.org/10.1016/j.clinbiochem.2005.08.008
16. EREL O. A novel automated direct measurement method for total antioxidant capacity using a new generationmore stable ABTS radical cation. Clin Biochem 2004; 37: 277-85. http://dx.doi.org/10.1016/j.clinbiochem.2003.11.015
17. HARMAM, HARMA M, EREL O. Increased oxidative stress in patients with hydatidiform mole. Swiss MedWkly 2003; 133: 563-6.
18. CHUNG KY, LEE SJ, CHUNG SM, LEE MY, BAE ON, et al. Generation of free radical by interaction of iron with thiols in human plasma and its possible significance. Thromb Res 2005; 116: 157-64. http://dx.doi.org/10.1016/j.thromres.2004.11.021
19. SEN CK. Redox signaling and the emerging therapeutic potential of thiol antioxidants. Biochem Pharmacol 1998; 55: 1747-58. http://dx.doi.org/10.1016/S0006-2952(97)00672-2
20. WLODEK L. Beneficial and harmful effects of thiols. Pol J Pharmacol 2002; 54: 215-23.
21. CAROLINA M, DA COSTA, RITA CC DOS SANTOS, EMERSON SL. A simple automated procedure for thiol measurement in human serum samples J Bras Patol Med Lab 2006; 42: 345-50.
22. HU ML. Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol. 1994; 233: 380-5. http://dx.doi.org/10.1016/S0076-6879(94)33044-1
23. LEE H, SONG M, SHIN N, SHIN CH, MIN BS, et al. Diagnostic significance of serum HMGB1 in colorectal carcinomas. PLoS One. 2012; 7: 34318. http://dx.doi.org/10.1371/journal.pone.0034318
24. ANANT NB, ROHIT M, ABDULLAH F, AMIT V, DWARAKANATH BS. Cancer biomarkers-Current perspectives. Indian J Med Res 2010; 132: 129-49
25. BART ŁK, TADEUSZ Ł. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer. Polski Przegla{ogonek}d Chirurgiczny 2012; 84: 86-92.
26. ROZENBERG O, AVIRAM M. S-Glutathionylation regulates HDL-associated paraoxonase 1 (PON1) activity. Biochem Biophys Res Commun 2006; 351: 492-8. http://dx.doi.org/10.1016/j.bbrc.2006.10.059
27. ERTURK C, ALTAY MA, SELEK S, KOCYIGIT A. Paraoxonase-1 activity and oxidative status in patients with knee osteoarthritis and their relationship with radiologicaland clinical parameters. Scand J Clin Lab Invest. 2012 [Epub ahead of print]. http://dx.doi.org/10.3109/00365513.2012.687116
28. ARTHUR F BANNE, AMIR AMIRI, RONALD W PERO. Reduced level of serum thiols in patients with a diagnosis of active disease. J Anti Aging Med. 2003; 6(4): 327-34. http://dx.doi.org/10.1089/109454503323028920
29. ICIEK M, CHWATKO G, LORENC-KOCI E, BALD E, WLODEK L. Plasma levels of total, free and protein bound thiols as well as sulfane sulfur in different age groups of rats. Acta Biochim Pol. 2004; 51: 815-24.
30. GIUSTARINI D, ROSSI R, MILZANI A, COLOMBO R, DALLE-DONNE I. S-Glutathionylation: from redox regulation of protein functions to human diseases. J Cell Mol Med 2004; 8: 201-12. http://dx.doi.org/10.1111/j.1582-4934.2004.tb00275.x